NFKB1 and rheumatoid arthritis: Collectively, GC intervention may reduce RA-induced joint inflammation and alleviate joint swelling and damage by inhibiting LPS-producing bacteria, lowering LPS synthesis, and thereby suppressing the activation of the TLR-4/NF-κB pathway in joint tissues.